Ketorenal Amino Tablet contains Alpha Ketoanalogue (NA), a specialized compound used primarily as a dietary supplement in the management of chronic kidney disease (CKD). This medication provides essential ketoanalogues of amino acids, which serve as nitrogen-free precursors that the body can convert into amino acids, thereby supporting protein synthesis while minimizing nitrogenous waste production. Ketorenal Amino is indicated for patients with impaired renal function who require a low-protein diet to reduce the burden on the kidneys and delay the progression of renal insufficiency. By supplementing with Alpha Ketoanalogue, the tablet helps maintain nutritional status and prevent protein-energy malnutrition, a common complication in CKD. It is typically prescribed alongside dietary protein restriction and under medical supervision to optimize therapeutic outcomes. The use of Ketorenal Amino Tablet may also reduce the accumulation of uremic toxins, improving patient well-being and potentially delaying the need for dialysis. Dosage and administration should be individualized based on the patient’s renal function, nutritional status, and clinical response. Caution is advised in patients with hypersensitivity to any component of the formulation. Regular monitoring of renal parameters and nutritional markers is recommended during therapy.